Nathalie Laurent-Britzen
Erlangen, BY 91054, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326.
Journal: Cancers
Published: September 25, 2025
Early Gut-Vascular Barrier Breakdown Precedes Colitis Onset in Murine Models.
Journal: Cellular and molecular gastroenterology and hepatology
Published: August 01, 2025
Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer.
Journal: Cell death discovery
Published: December 20, 2023
Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer.
Journal: Cancers
Published: August 18, 2023
Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD.
Journal: Frontiers in cell and developmental biology
Published: May 22, 2023
Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases.
Journal: International journal of molecular sciences
Published: February 15, 2023
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.
Journal: Frontiers in cell and developmental biology
Published: June 22, 2022
Last Updated: 09/26/2026